FOXO TECHNOLOGIES INC. Entity Listing, Par Value Per Share
FOXO TECHNOLOGIES INC. (FOXO) reported Entity Listing, Par Value Per Share of $0.00 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Cover Page
dei:EntityListingParValuePerShare · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. entity listing, par value per share for the quarter ending 2026-03-31 was $0.00, a 0.00% change year-over-year.
- FOXO TECHNOLOGIES INC. entity listing, par value per share for the quarter ending 2025-03-31 was $0.00.
- FOXO TECHNOLOGIES INC. entity listing, par value per share for fiscal 2025 was $0.00, a 0.00% change from fiscal 2024.
- FOXO TECHNOLOGIES INC. entity listing, par value per share for fiscal 2024 was $0.00.
| Period end | Entity Listing, Par Value Per Share 3 month | Entity Listing, Par Value Per Share 6 month | Entity Listing, Par Value Per Share 9 month | Entity Listing, Par Value Per Share 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | $0.00 10-K · filed 2026-04-15 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-10 | |||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-19 | |||
| 2025-03-31 | $0.00 10-Q/A · filed 2025-08-19 | |||
| 2024-12-31 | $0.00 10-K · filed 2025-04-15 | |||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-19 | |||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |